Clinical Trial Update: Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing IL-4R-alpha inhibition effects on the respiratory microbiome and immunologic correlates in severe asthma; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: University of Michigan | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2024-10-23